Transversus Abdominis Plan (TAP) Block In Transcatheter Aortic Valve Implantation (TAVI)
NCT ID: NCT06762288
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-12-28
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions
NCT06576128
Comparison of the Analgesic Efficacy of Chest Wall Blocks in Coronary Artery Bypass Surgery
NCT06657261
Effect of Transversus Thoracic Muscle Plane Block (TTMP) on Analgesia
NCT06601530
Efficacy of the Ultrasound-guided Transversus Abdominis Plane Block in Open Aortic Abdominal Aneurysm Repair Surgery
NCT02292667
TAP Block On Abdominal Surgery Patients With General Anesthesia
NCT04364477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mostly the femoral artery is preferred for TAVİ access because it has a large lumen (8-9 mm) and has less anatomical variation. After the inguinal ligament, the iliac artery, originating from the abdominal aorta, is called the femoral artery. Since this region is safe, it is preferred in cardiac interventions.
Transversus abdominis plane (TAP) block aims to block the ilioinguinal and iliohypogastric nerves which contribute to the sensory innervation of the femoral region used for endovascular cardiac interventions. No studies have been found on the analgesic efficacy of TAP block in TAVİ procedures.
Local anesthesia and sedation as standard procedure will be applied to the control group (C) (n: 25). In TAP block group (TAP) (n:25) standard procedure and unilateral USG-guided TAP block will be performed. In both groups, an additional dose of anesthetic drugs (midazolam 0.05mg/kg and fentanyl 1mcg/kg or propofol 0.5-1mg/kg) will be administered slowly IV when the patient feels pain, wakes up (BIS\>80) or moves.
Patients' demographic data, hemodynamic parameters, total anesthetic drug consumption, procedure duration, complications seen during the procedure will be recorded. The highest pain level felt during procedure, when placing and withdrawing sheath and 4 hours after removal will be recorded according to the Numeric rating scale-11 (NRS-11) scoring system. 5-point Likert scale will be used for patient and physician satisfaction.
Cardiac endovascular catheterization procedures such as TAVI are often anxiety-provoking and uncomfortable for patients. The anesthesia method may vary depending on the experience of the cardiology team, the characteristics of the patients and the procedure to be performed. In TAVI procedures, which were initially performed under general anesthesia, a combination of local anesthesia and sedation was preferred as the team's experience developed. Hemodynamic stability and patient immobilization are the main goals of the anesthetic method during TAVI. Due to pain, patients may develop hemodynamic instability and may move. This is an undesirable situation for cardiac patients. It may affect the quality of the procedure for the cardiologist and may cause complications and longer procedure times. Examining the effectiveness of anesthesia by applying TAP block accompanied by sedation and physician and patient satisfaction during and after the procedure forms the basis of the research. First aim of the study is to demonstrate the analgesic effectiveness of ultrasound-guided TAP block application in the femoral region before the procedure in 50 patients who underwent TAVI. Secondary aims are to reduce the need for anesthetic drugs and to investigate patient and physician satisfaction during and after the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Block group
Local anesthesia and sedation will be applied as standard procedure and unilateral USG-guided TAP block will be performed. In both groups, an additional dose of anesthetic drugs (midazolam 0.05mg/kg and fentanyl 1mcg/kg or propofol 0.5-1mg/kg) will be administered slowly IV when the patient feels pain, wakes up (BIS\>80) or moves.
Ultrasound
Sedation and local anesthesia to the surgical field will be applied as standard procedure and unilateral USG-guided TAP block will be performed to the patients who will undergo TAVİ.
Local anesthesia and sedation
Sedation and local anesthesia to the surgical field will be applied to the patients who will undergo TAVİ.
Control group
Local anesthesia and sedation will be applied as standard procedure in the control group (C) (n: 25). In both groups, an additional dose of anesthetic drugs (midazolam 0.05mg/kg and fentanyl 1mcg/kg or propofol 0.5-1mg/kg or ) will be administered slowly IV when the patient feels pain, wakes up (BIS\>80) or moves
Local anesthesia and sedation
Sedation and local anesthesia to the surgical field will be applied to the patients who will undergo TAVİ.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Sedation and local anesthesia to the surgical field will be applied as standard procedure and unilateral USG-guided TAP block will be performed to the patients who will undergo TAVİ.
Local anesthesia and sedation
Sedation and local anesthesia to the surgical field will be applied to the patients who will undergo TAVİ.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years of age
* INR \< 1,5
* elective procedures
* Signing the volunteer consent form
* Providing optimal images in ultrasound imaging
Exclusion Criteria
* emergency procedures
* morbidly obese patients (BMI\>35kg/m2)
* Advanced decompensated heart failure with New york Heart Association (NYHA) stage 4
* Those who have skin infection, lesion, hematoma in the area to be blocked
* Cannot be communicated and cannot be given a position
* Allergic to the prescribed medications
* Pregnants
* Those who refused to sign volunteer consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kerem Erkalp, MD, Prof
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerem Erkalp, professor
Role: STUDY_CHAIR
Istanbul University - Cerrahpasa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University-Cerrahpaşa
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Kerem Erkalp, professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.